HIV blocks interferon induction in human dendritic cells and macrophages by dysregulation of TBK1

Journal of Virology

Volumn 89, Issue 13, 2015, Pages 6575-6584

  Harman, Andrew N ^a   Nasr, Najla ^a   Feetham, Alexandra ^a   Galoyan, Ani ^a   Alshehri, Abdullateef A ^a   Rambukwelle, Dharshini ^a   Botting, Rachel A ^a   Hiener, Bonnie M ^a   Diefenbach, Eve ^a   Diefenbach, Russell J ^a   Kim, Min ^a   Mansell, Ashley ^b   Cunningham, Anthony L ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; BINDING PROTEIN; INTERFERON; LYSINE; PATTERN RECOGNITION RECEPTOR; PHOSPHOTRANSFERASE; TANK BINDING KINASE 1; UNCLASSIFIED DRUG; VIF PROTEIN; VPR PROTEIN; PROTEIN SERINE THREONINE KINASE; TBK1 PROTEIN, HUMAN; VIF PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; VPR PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

ARTICLE; AUTOPHOSPHORYLATION; CONTROLLED STUDY; DENDRITIC CELL; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GENE EXPRESSION; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; MICROBIAL ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SENDAI VIRUS; SIGNAL TRANSDUCTION; TYPE I IFN GENE; TYPE III IFN GENE; UBIQUITINATION; VIRUS CELL INTERACTION; ANTAGONISTS AND INHIBITORS; CELL CULTURE; HOST PATHOGEN INTERACTION; IMMUNE EVASION; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION; PROTEIN PROCESSING; VIROLOGY;

HUMAN HERPESVIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 1; SENDAI VIRUS;

CELLS, CULTURED; DENDRITIC CELLS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; INTERFERONS; MACROPHAGES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; UBIQUITINATION; VIF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; VPR GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84930922500     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00889-15     Document Type: Article

References (61)

1. Harman AN, Kim M, Nasr N, Sandgren KJ, Cameron PU. 2013. Tissue dendritic cells as portals for HIV entry. Rev Med Virol 23:319-333. http://dx.doi.org/10.1002/rmv.1753.
2. Harman AN, Bye CR, Nasr N, Sandgren KJ, Kim M, Mercier SK, Botting RA, Lewin SR, Cunningham AL, Cameron PU. 2013. Identification of lineage relationships and novel markers of blood and skin human dendritic cells. J Immunol 190:66-79. http://dx.doi.org/10.4049/jimmunol.1200779.
3. Nasr N, Lai J, Botting RA, Mercier SK, Harman AN, Kim M, Turville S, Center RJ, Domagala T, Gorry PR, Olbourne N, Cunningham AL. 2014. Inhibition of two temporal phases of HIV-1 transfer from primary Langerhans cells to T cells: the role of langerin. J Immunol 193:2554-2564. http://dx.doi.org/10.4049/jimmunol.1400630.
4. Shen R, Kappes JC, Smythies LE, Richter HE, Novak L, Smith PD. 2014. Vaginal myeloid dendritic cells transmit founder HIV-1. J Virol 88:7683-7688. http://dx.doi.org/10.1128/JVI.00766-14.
5. Ganor Y, Zhou Z, Tudor D, Schmitt A, Vacher-Lavenu MC, Gibault L, Thiounn N, Tomasini J, Wolf JP, Bomsel M. 2010. Within 1 h, HIV-1 uses viral synapses to enter efficiently the inner, but not outer, foreskin mucosa and engages Langerhans-T cell conjugates. Mucosal Immunol 3:506-522. http://dx.doi.org/10.1038/mi.2010.32.
6. Cavarelli M, Foglieni C, Rescigno M, Scarlatti G. 2013. R5 HIV-1 envelope attracts dendritic cells to cross the human intestinal epithelium and sample luminal virions via engagement of the CCR5. EMBO Mol Med 5:776-794. http://dx.doi.org/10.1002/emmm.201202232.
7. Cunningham AL, Harman A, Nasr N. 2013. Initial HIV mucosal infection and dendritic cells. EMBO Mol Med 5:658-660. http://dx.doi.org/10.1002/emmm.201202763.
8. McElrath MJ, Smythe K, Randolph-Habecker J, Melton KR, Goodpaster TA, Hughes SM, Mack M, Sato A, Diaz G, Steinbach G, Novak RM, Curlin ME, Lord JD, Maenza J, Duerr A, Frahm N, Hladik F, Network NHVT. 2013. Comprehensive assessment of HIV target cells in the distal human gut suggests increasing HIV susceptibility toward the anus. J Acquir Immune Defic Syndr 63:263-271. http://dx.doi.org/10.1097/QAI .0b013e3182898392.
9. Harman AN, Lai J, Turville S, Samarajiwa S, Gray L, Marsden V, Mercier SK, Jones K, Nasr N, Rustagi A, Cumming H, Donaghy H, Mak J, Gale M, Jr, Churchill M, Hertzog P, Cunningham AL. 2011. HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production. Blood 118:298-308. http://dx.doi.org/10.1182/blood-2010-07-297721.
10. Nasr N, Maddocks S, Turville SG, Harman AN, Woolger N, Helbig KJ, Wilkinson J, Bye CR, Wright TK, Rambukwelle D, Donaghy H, Beard MR, Cunningham AL. 2012. HIV-1 infection of human macrophages directly induces viperin which inhibits viral production. Blood 120:778-788. http://dx.doi.org/10.1182/blood-2012-01-407395.
11. Cunningham AL, Donaghy H, Harman AN, Kim M, Turville SG. 2010. Manipulation of dendritic cell function by viruses. Curr Opin Microbiol 13:524-529. http://dx.doi.org/10.1016/j.mib.2010.06.002.
12. Devasthanam AS. 2014. Mechanisms underlying the inhibition of interferon signaling by viruses. Virulence 5:270 -277. http://dx.doi.org/10.4161/viru.27902.
13. Kawai T, Akira S. 2011. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34:637-650. http://dx.doi.org/10.1016/j.immuni.2011.05.006.
14. Barber GN. 2014. STING-dependent cytosolic DNA sensing pathways. Trends Immunol 35:88-93. http://dx.doi.org/10.1016/j.it.2013.10.010.
15. Ma X, Helgason E, Phung QT, Quan CL, Iyer RS, Lee MW, Bowman KK, Starovasnik MA, Dueber EC. 2012. Molecular basis of Tank-binding kinase 1 activation by transautophosphorylation. Proc Natl Acad SciUSA 109:9378-9383. http://dx.doi.org/10.1073/pnas.1121552109.
16. Siu KL, Kok KH, Ng MH, Poon VK, Yuen KY, Zheng BJ, Jin DY. 2009. Severe acute respiratory syndrome coronavirusMprotein inhibits type I interferon production by impeding the formation of TRAF3.TANK.TBK1/IKKepsilon complex. J Biol Chem 284:16202-16209. http://dx.doi.org/10.1074/jbc.M109.008227.
17. Kaukinen P, Sillanpaa M, Nousiainen L, Melen K, Julkunen I. 2013. Hepatitis C virus NS2 protease inhibits host cell antiviral response by inhibiting IKKepsilon and TBK1 functions. J Med Virol 85:71-82. http://dx.doi.org/10.1002/jmv.23442.
18. Yu S, Chen J, Wu M, Chen H, Kato N, Yuan Z. 2010. Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3. J Gen Virol 91:2080-2090. http://dx.doi.org/10.1099/vir.0.020552-0.
19. Chen X, Yang X, Zheng Y, Yang Y, Xing Y, Chen Z. 2014. SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex. Protein Cell 5:369-381. http://dx.doi.org/10.1007/s13238-014-0026-3.
20. Brzozka K, Finke S, Conzelmann KK. 2005. Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J Virol 79:7673-7681. http://dx.doi.org/10.1128/JVI.79.12.7673-7681.2005.
21. Duggal NK, Emerman M. 2012. Evolutionary conflicts between viruses and restriction factors shape immunity. Nat Rev Immunol 12:687-695. http://dx.doi.org/10.1038/nri3295.
22. Doehle BP, Chang K, Fleming L, McNevin J, Hladik F, McElrath MJ, Gale M, Jr. 2012. Vpu-deficient HIV strains stimulate innate immune signaling responses in target cells. J Virol 86:8499-8506. http://dx.doi.org/10.1128/JVI.00424-12.
23. Doehle BP, Chang K, Rustagi A, McNevin J, McElrath MJ, Gale M, Jr. 2012. Vpu mediates depletion of interferon regulatory factor 3 during HIV infection by a lysosome-dependent mechanism. J Virol 86:8367-8374. http://dx.doi.org/10.1128/JVI.00423-12.
24. Doehle BP, Hladik F, McNevin JP, McElrath MJ, Gale M, Jr. 2009. Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells. J Virol 83:10395-10405. http://dx.doi.org/10.1128/JVI.00849-09.
25. Okumura A, Alce T, Lubyova B, Ezelle H, Strebel K, Pitha PM. 2008. HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation. Virology 373:85-97. http://dx.doi.org/10.1016/j.virol.2007.10.042.
26. Hotter D, Kirchhoff F, Sauter D. 2013. HIV-1 Vpu does not degrade interferon regulatory factor 3. J Virol 87:7160-7165. http://dx.doi.org/10.1128/JVI.00526-13.
27. Harman AN, Wilkinson J, Bye CR, Bosnjak L, Stern JL, Nicholle M, Lai J, Cunningham AL. 2006. HIV induces maturation of monocyte-derived dendritic cells and Langerhans cells. J Immunol 177:7103-7113. http://dx .doi.org/10.4049/jimmunol.177.10.7103.
28. Mercier SK, Donaghy H, Botting RA, Turville SG, Harman AN, Nasr N, Ji H, Kusebauch U, Mendoza L, Shteynberg D, Sandgren K, Simpson RJ, Moritz RL, Cunningham AL. 2013. The microvesicle component of HIV-1 inocula modulates dendritic cell infection and maturation and enhances adhesion to and activation of T lymphocytes. PLoS Pathog 9:e1003700. http://dx.doi.org/10.1371/journal.ppat.1003700.
29. Harman AN, Kraus M, Bye CR, Byth K, Turville SG, Tang O, Mercier SK, Nasr N, Stern JL, Slobedman B, Driessen C, Cunningham AL. 2009. HIV-1-infected dendritic cells show 2 phases of gene expression changes, with lysosomal enzyme activity decreased during the second phase. Blood 114:85-94. http://dx.doi.org/10.1182/blood-2008-12-194845.
30. Nasr N, Harman A, Turville S, Cunningham AL. 2014. HIV infection of dendritic cells. Methods Mol Biol 1087:221-232. http://dx.doi.org/10.1007/978-1-62703-670-2_18.
31. Uze G, Monneron D. 2007. IL-28 and IL-29: newcomers to the interferon family. Biochimie 89:729 -734. http://dx.doi.org/10.1016/j .biochi.2007.01.008.
32. Helgason E, Phung QT, Dueber EC. 2013. Recent insights into the complexity of Tank-binding kinase 1 signaling networks: the emerging role of cellular localization in the activation and substrate specificity of TBK1. FEBS Lett 587:1230-1237. http://dx.doi.org/10.1016/j.febslet.2013.01.059.
33. Pilli M, Arko-Mensah J, Ponpuak M, Roberts E, Master S, Mandell MA, Dupont N, Ornatowski W, Jiang S, Bradfute SB, Bruun JA, Hansen TE, Johansen T, Deretic V. 2012. TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation. Immunity 37:223-234. http://dx.doi.org/10.1016/j.immuni.2012.04.015.
34. Soderberg O, Gullberg M, Jarvius M, Ridderstrale K, Leuchowius KJ, Jarvius J, Wester K, Hydbring P, Bahram F, Larsson LG, Landegren U. 2006. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nature methods 3:995-1000. http://dx.doi.org/10.1038/nmeth947.
35. Wang D, Fang L, Li P, Sun L, Fan J, Zhang Q, Luo R, Liu X, Li K, Chen H, Chen Z, Xiao S. 2011. The leader proteinase of foot-and-mouth disease virus negatively regulates the type I interferon pathway by acting as a viral deubiquitinase. J Virol 85:3758-3766. http://dx.doi.org/10.1128/JVI.02589-10.
36. Zhu H, Zheng C, Xing J, Wang S, Li S, Lin R, Mossman KL. 2011. Varicella-zoster virus immediate-early protein ORF61 abrogates the IRF3-mediated innate immune response through degradation of activated IRF3. J Virol 85:11079-11089. http://dx.doi.org/10.1128/JVI.05098-11.
37. Bonjardim CA, Ferreira PC, Kroon EG. 2009. Interferons: signaling, antiviral and viral evasion. Immunol Lett 122:1-11. http://dx.doi.org/10.1016/j.imlet.2008.11.002.
38. Liang Q, Fu B, Wu F, Li X, Yuan Y, Zhu F. 2012. ORF45 of Kaposi's sarcoma-associated herpesvirus inhibits phosphorylation of interferon regulatory factor 7 by IKKepsilon and TBK1 as an alternative substrate. J Virol 86:10162-10172. http://dx.doi.org/10.1128/JVI.05224-11.
39. Tojima Y, Fujimoto A, Delhase M, Chen Y, Hatakeyama S, Nakayama K, Kaneko Y, Nimura Y, Motoyama N, Ikeda K, Karin M, Nakanishi M. 2000. NAK is an IkappaB kinase-activating kinase. Nature 404:778-782. http://dx.doi.org/10.1038/35008109.
40. Yu T, Yi YS, Yang Y, Oh J, Jeong D, Cho JY. 2012. The pivotal role of TBK1 in inflammatory responses mediated by macrophages. Mediators Inflamm 2012:979105. http://dx.doi.org/10.1155/2012/979105.
41. LaFleur DW, Nardelli B, Tsareva T, Mather D, Feng P, Semenuk M, Taylor K, Buergin M, Chinchilla D, Roshke V, Chen G, Ruben SM, Pitha PM, Coleman TA, Moore PA. 2001. Interferon-kappa, a novel type I interferon expressed in human keratinocytes. J Biol Chem 276:39765-39771. http://dx.doi.org/10.1074/jbc.M102502200.
42. Nardelli B, Zaritskaya L, Semenuk M, Cho YH, LaFleur DW, Shah D, Ullrich S, Girolomoni G, Albanesi C, Moore PA. 2002. Regulatory effect of IFN-kappa, a novel type I IFN, on cytokine production by cells of the innate immune system. J Immunol 169:4822-4830. http://dx.doi.org/10.4049/jimmunol.169.9.4822.
43. Kotenko SV. 2011. IFN-lambdas. Curr Opin Immunol 23:583-590. http://dx.doi.org/10.1016/j.coi.2011.07.007.
44. Ank N, Iversen MB, Bartholdy C, Staeheli P, Hartmann R, Jensen UB, Dagnaes-Hansen F, Thomsen AR, Chen Z, Haugen H, Klucher K, Paludan SR. 2008. An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity. J Immunol 180:2474-2485. http://dx.doi.org/10.4049/jimmunol.180.4.2474.
45. Seo Y, Kim M, Choi M, Kim S, Park K, Oh I, Chung S, Suh H, Hong S, Park S. 2011. Possible role of phosphoinositide-3-kinase in Mx1 protein translation and antiviral activity of interferon-omega-stimulated HeLa cells. Pharmacology 87:224-231. http://dx.doi.org/10.1159/000324536.
46. Fung KY, Mangan NE, Cumming H, Horvat JC, Mayall JR, Stifter SA, De Weerd N, Roisman LC, Rossjohn J, Robertson SA, Schjenken JE, Parker B, Gargett CE, Nguyen HP, Carr DJ, Hansbro PM, Hertzog PJ. 2013. Interferon-epsilon protects the female reproductive tract from viral and bacterial infection. Science 339:1088-1092. http://dx.doi.org/10.1126/science.1233321.
47. Solis M, Nakhaei P, Jalalirad M, Lacoste J, Douville R, Arguello M, Zhao T, Laughrea M, Wainberg MA, Hiscott J. 2011. RIG-I-mediated antiviral signaling is inhibited in HIV-1 infection by a protease-mediated sequestration of RIG-I. J Virol 85:1224-1236. http://dx.doi.org/10.1128/JVI.01635-10.
48. Zheng D, Chen G, Guo B, Cheng G, Tang H. 2008. PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production. Cell Res 18:1105-1113. http://dx.doi.org/10.1038/cr.2008.294.
49. Ding Z, Fang L, Jing H, Zeng S, Wang D, Liu L, Zhang H, Luo R, Chen H, Xiao S. 2014. Porcine epidemic diarrhea virus nucleocapsid protein antagonizes beta interferon production by sequestering the interaction between IRF3 and TBK1. J Virol 88:8936-8945. http://dx.doi.org/10.1128/JVI.00700-14.
50. Prins KC, Cardenas WB, Basler CF. 2009. Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1. J Virol 83:3069-3077. http://dx.doi.org/10.1128/JVI .01875-08.
51. Manel N, Hogstad B, Wang Y, Levy DE, Unutmaz D, Littman DR. 2010. Acryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 467:214-217. http://dx.doi.org/10.1038/nature09337.
52. Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, Segeral E, Yatim A, Emiliani S, Schwartz O, Benkirane M. 2011. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474:654-657. http://dx.doi.org/10.1038/nature10117.
53. Fenton-May AE, Dibben O, Emmerich T, Ding H, Pfafferott K, Aasa-Chapman MM, Pellegrino P, Williams I, Cohen MS, Gao F, Shaw GM, Hahn BH, Ochsenbauer C, Kappes JC, Borrow P. 2013. Relative resistance of HIV-1 founder viruses to control by interferon-alpha. Retrovirology 10:146. http://dx.doi.org/10.1186/1742-4690-10-146.
54. Sandler NG, Bosinger SE, Estes JD, Zhu RT, Tharp GK, Boritz E, Levin D, Wijeyesinghe S, Makamdop KN, del Prete GQ, Hill BJ, Timmer JK, Reiss E, Yarden G, Darko S, Contijoch E, Todd JP, Silvestri G, Nason M, Norgren RB, Jr, Keele BF, Rao S, Langer JA, Lifson JD, Schreiber G, Douek DC. 2014. Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression. Nature 511:601-605. http://dx.doi.org/10.1038/nature13554.
55. Li G, Cheng M, Nunoya J, Cheng L, Guo H, Yu H, Liu YJ, Su L, Zhang L. 2014. Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice. PLoS Pathog 10:e1004291. http://dx.doi.org/10.1371/journal.ppat.1004291.
56. Li Q, Estes JD, Schlievert PM, Duan L, Brosnahan AJ, Southern PJ, Reilly CS, Peterson ML, Schultz-Darken N, Brunner KG, Nephew KR, Pambuccian S, Lifson JD, Carlis JV, Haase AT. 2009. Glycerol monolaurate prevents mucosal SIV transmission. Nature 458:1034-1038. http://dx.doi.org/10.1038/nature07831.
57. Herbein G, Varin A. 2010. The macrophage in HIV-1 infection: from activation to deactivation? Retrovirology 7:33. http://dx.doi.org/10.1186/1742-4690-7-33.
58. Xue J, Schmidt SV, Sander J, Draffehn A, Krebs W, Quester I, De Nardo D, Gohel TD, Emde M, Schmidleithner L, Ganesan H, Nino-Castro A, Mallmann MR, Labzin L, Theis H, Kraut M, Beyer M, Latz E, Freeman TC, Ulas T, Schultze JL. 2014. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 40:274-288. http://dx.doi.org/10.1016/j.immuni.2014.01.006.
59. Schlaepfer E, Rochat MA, Duo L, Speck RF. 2014. Triggering TLR2, -3, -4, -5, and -8 reinforces the restrictive nature of M1- and M2-polarized macrophages to HIV. J Virol 88:9769-9781. http://dx.doi.org/10.1128/JVI.01053-14.
60. Cassol E, Cassetta L, Rizzi C, Alfano M, Poli G. 2009. M1 and M2a polarization of human monocyte-derived macrophages inhibits HIV-1 replication by distinct mechanisms. J Immunol 182:6237-6246. http://dx .doi.org/10.4049/jimmunol.0803447.
61. Albright AV, Shieh JT, O'Connor MJ, Gonzalez-Scarano F. 2000. Characterization of cultured microglia that can be infected by HIV-1. J Neurovirol 6(Suppl 1):S53-S60.